Citation: Sl. Rogers et Lt. Friedhoff, LONG-TERM EFFICACY AND SAFETY OF DONEPEZIL IN THE TREATMENT OF ALZHEIMERS-DISEASE - AN INTERIM ANALYSIS OF THE RESULTS OF A US MULTICENTER OPEN-LABEL EXTENSION STUDY, European neuropsychopharmacology, 8(1), 1998, pp. 67-75
Citation: Sl. Rogers et Lt. Friedhoff, PHARMACOKINETIC AND PHARMACODYNAMIC PROFILE OF DONEPEZIL HCL FOLLOWING SINGLE ORAL DOSES, British journal of clinical pharmacology, 46, 1998, pp. 1-6
Authors:
ROGERS SL
COOPER NM
SUKOVATY R
PEDERSON JE
LEE JN
FRIEDHOFF LT
Citation: Sl. Rogers et al., PHARMACOKINETIC AND PHARMACODYNAMIC PROFILE OF DONEPEZIL HCL FOLLOWING MULTIPLE ORAL DOSES, British journal of clinical pharmacology, 46, 1998, pp. 7-12
Citation: Pj. Tiseo et al., PHARMACOKINETIC AND PHARMACODYNAMIC PROFILE OF DONEPEZIL HCL FOLLOWING EVENING ADMINISTRATION, British journal of clinical pharmacology, 46, 1998, pp. 13-18
Citation: Pj. Tiseo et al., METABOLISM AND ELIMINATION OF C-14-DONEPEZIL IN HEALTHY-VOLUNTEERS - A SINGLE-DOSE STUDY, British journal of clinical pharmacology, 46, 1998, pp. 19-24
Citation: Pj. Tiseo et al., CONCURRENT ADMINISTRATION OF DONEPEZIL HCL AND CIMETIDINE - ASSESSMENT OF PHARMACOKINETIC CHANGES FOLLOWING SINGLE AND MULTIPLE DOSES, British journal of clinical pharmacology, 46, 1998, pp. 25-29
Citation: Pj. Tiseo et al., CONCURRENT ADMINISTRATION OF DONEPEZIL HCL AND KETOCONAZOLE - ASSESSMENT OF PHARMACOKINETIC CHANGES FOLLOWING SINGLE AND MULTIPLE DOSES, British journal of clinical pharmacology, 46, 1998, pp. 30-34
Citation: Pj. Tiseo et al., CONCURRENT ADMINISTRATION OF DONEPEZIL HCL AND THEOPHYLLINE - ASSESSMENT OF PHARMACOKINETIC CHANGES FOLLOWING MULTIPLE-DOSE ADMINISTRATION IN HEALTHY-VOLUNTEERS, British journal of clinical pharmacology, 46, 1998, pp. 35-39
Citation: Pj. Tiseo et al., CONCURRENT ADMINISTRATION OF DONEPEZIL HCL AND DIGOXIN - ASSESSMENT OF PHARMACOKINETIC CHANGES, British journal of clinical pharmacology, 46, 1998, pp. 40-44
Citation: Pj. Tiseo et al., THE EFFECT OF MULTIPLE DOSES OF DONEPEZIL HCL ON THE PHARMACOKINETIC AND PHARMACODYNAMIC PROFILE OF WARFARIN, British journal of clinical pharmacology, 46, 1998, pp. 45-50
Authors:
TISEO PJ
VARGAS R
PERDOMO CA
FRIEDHOFF LT
Citation: Pj. Tiseo et al., AN EVALUATION OF THE PHARMACOKINETICS OF DONEPEZIL HCL IN PATIENTS WITH IMPAIRED HEPATIC-FUNCTION, British journal of clinical pharmacology, 46, 1998, pp. 51-55
Citation: Pj. Tiseo et al., AN EVALUATION OF THE PHARMACOKINETICS OF DONEPEZIL HCL IN PATIENTS WITH MODERATELY TO SEVERELY IMPAIRED RENAL-FUNCTION, British journal of clinical pharmacology, 46, 1998, pp. 56-60
Authors:
ROGERS SL
FARLOW MR
DOODY RS
MOHS R
FRIEDHOFF LT
ALBALA B
BAUMEL B
BOOKER G
DEXTER J
FARMER M
FEIGHNER JP
FERRIS S
GORDON B
GORMAN DG
HANNA G
HARRELL LE
HUBBARD R
KENNEDY J
MCCARTHY J
SCHARRE DW
SCHAERF F
SCHNEIDER L
SELTZER B
SIEGAL A
STARK SR
STRAUSS A
WALSHE TM
Citation: Sl. Rogers et al., A 24-WEEK, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF DONEPEZIL IN PATIENTS WITH ALZHEIMERS-DISEASE, Neurology, 50(1), 1998, pp. 136-145
Authors:
TISEO PJ
ROGERS SL
PERDOMO CA
FRIEDHOFF LT
Citation: Pj. Tiseo et al., THE EFFECT OF CIMETIDINE AND KETOCONAZOLE ON THE PHARMACOKINETICS OF DONEPEZIL HC1, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 108-108
Citation: Sl. Rogers et al., DONEPEZIL IMPROVES COGNITION AND GLOBAL FUNCTION IN ALZHEIMER-DISEASE- A 15-WEEK, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY, Archives of internal medicine, 158(9), 1998, pp. 1021-1031
Citation: Lt. Friedhoff et Sl. Rogers, CORRELATION BETWEEN THE CLINICAL EFFICACY OF DONEPEZIL HCL (E2020) AND RED-BLOOD-CELL (RBC) ACETYLCHOLINESTERASE (ACHE) INHIBITION IN PATIENTS WITH ALZHEIMERS-DISEASE (AD), Clinical pharmacology and therapeutics, 61(2), 1997, pp. 49-49
Citation: Sl. Rogers et Lt. Friedhoff, THE PHARMACOKINETIC (PK) AND PHARMACODYNAMIC (PD) PROFILE OF DONEPEZIL HCL (E2020) FOLLOWING SINGLE AND MULTIPLE ORAL DOSES, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 63-63
Citation: Pj. Tiseo et al., THE PHARMACOKINETIC PROFILE OF DONEPEZIL HCL (E2020) IN PATIENTS WITHIMPAIRED LIVER-FUNCTION, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 75-75
Citation: Sl. Rogers et al., PHARMACOKINETICS OF DONEPEZIL HCL (E2020) ARE UNCHANGED IN PATIENTS WITH IMPAIRED RENAL-FUNCTION, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 91-91
Authors:
ROGERS SL
FRIEDHOFF LT
APTER JT
RICHTER RW
HARTFORD JT
WALSHE TM
BAUMEL B
LINDEN RD
KINNEY FC
DOODY RS
BORISON RL
AHEM GL
Citation: Sl. Rogers et al., THE EFFICACY AND SAFETY OF DONEPEZIL IN PATIENTS WITH ALZHEIMERS-DISEASE - RESULTS OF A US MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, Dementia, 7(6), 1996, pp. 293-303
Citation: Sl. Rogers et al., E2020 PRODUCES BOTH CLINICAL GLOBAL AND COGNITIVE TEST IMPROVEMENT INPATIENTS WITH MILD TO MODERATELY SEVERE ALZHEIMERS-DISEASE - RESULTS OF A 30 WEEK PHASE-III TRIAL, Neurology, 46(2), 1996, pp. 14001-14001
Citation: Sl. Rogers et Lt. Friedhoff, E2020 IMPROVES COGNITION AND QUALITY-OF-LIFE IN PATIENTS WITH MILD-TO-MODERATE ALZHEIMERS-DISEASE - RESULTS OF A PHASE-II TRIAL, Neurology, 44(4), 1994, pp. 10000165-10000165
Authors:
ROGERS SL
SYTNIK B
KOVACS T
WALTERS EJ
MERTZ H
OHNING G
GOLODNER E
FRIEDHOFF LT
WALSH JH
Citation: Sl. Rogers et al., A STUDY OF THE PHARMACODYNAMICS OF E3810, A NEW AND PARTIALLY REVERSIBLE INHIBITOR OF H-VOLUNTEERS(K+ ATPASE, IN HEALTHY MALE), Gastroenterology, 104(4), 1993, pp. 180-180